Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib

<div>Growth inhibitory effect of palbociclib on SK-LMS-1 and SK-UT-1. Cells were cultivated on 96 plates and treated with increasing concentrations of palbociclib (3–1000 nmol/l) for 72 hours. The MTS assay was used for determining cell viability.</div>

Sarcoma

fig2

Figure 2

Figure 2: Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib 